600165 ST宁科生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-5.470-14.124-630.484-141.042-31.724
总资产报酬率 ROA (%)-2.627-3.881-21.032-14.906-6.409
投入资产回报率 ROIC (%)-3.149-7.569-55.433-24.808-9.274

边际利润分析
销售毛利率 (%)7.767-19.955-19.539-34.6210.084
营业利润率 (%)-53.982-24.842-162.216-172.692-39.561
息税前利润/营业总收入 (%)-48.211-29.372-125.849-130.799-25.362
净利润/营业总收入 (%)-54.237-36.648-167.102-180.357-40.912

收益指标分析
经营活动净收益/利润总额(%)30.295147.92850.91660.90792.316
价值变动净收益/利润总额(%)0.000-215.84814.378-6.631-14.389
营业外收支净额/利润总额(%)0.10630.1053.2664.3021.567

偿债能力分析
流动比率 (X)2.7052.7720.1130.1060.153
速动比率 (X)2.0482.3610.0590.0550.087
资产负债率 (%)47.11446.34688.91789.66575.079
带息债务/全部投入资本 (%)-0.112-0.16867.90059.72848.212
股东权益/带息债务 (%)-50,607.302-34,638.58533.56010.18954.847
股东权益/负债合计 (%)100.904104.6723.7263.73922.748
利息保障倍数 (X)-8.272-4.761-3.008-2.634-1.710

营运能力分析
应收账款周转天数 (天)81.92767.17364.58656.53715.543
存货周转天数 (天)120.38474.04486.28795.59575.511